M. Rutter

First name
M.
Middle name
K.
Last name
Rutter
Ajabnoor, A. M., Zghebi, S. S., Parisi, R., Ashcroft, D. M., Rutter, M. K., Doran, T., et al. (2022). Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study. Plos Med, 19, e1004003. http://doi.org/10.1371/journal.pmed.1004003
View
Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., et al. (2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113
View
Parisi, R., Rutter, M. K., Lunt, M., Young, H. S., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2015). Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink. J Invest Dermatol. http://doi.org/10.1038/jid.2015.87
View
Kontopantelis, E., Springate, D. A., Reeves, D., Ashcroft, D. M., Rutter, M. K., Buchan, I., & Doran, T. (2015). Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia. http://doi.org/10.1007/s00125-014-3473-8
View
Zghebi, S. S., Steinke, D. T., Rutter, M. K., Emsley, R. A., & Ashcroft, D. M. (2016). Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records. Diabetes Obes Metab. http://doi.org/10.1111/dom.12692
View
Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I., Sattar, N., Rutter, M. K., & Ashcroft, D. M. (2017). Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups. Diabetes Care. http://doi.org/10.2337/dc16-1616
View
Zghebi, S. S., Steinke, D. T., Carr, M. J., Rutter, M. K., Emsley, R. A., & Ashcroft, D. M. (2017). Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obes Metab. http://doi.org/10.1111/dom.12964
View
Zghebi, S. S., Rutter, M. K., Ashcroft, D. M., Salisbury, C., Mallen, C., Chew-Graham, C. A., et al. (2018). Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design. BMJ Open. http://doi.org/10.1136/bmjopen-2017-020926
View
Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I. E., Mamas, M. A., Sattar, N., et al. (2019). Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. Circulation. http://doi.org/10.1161/circulationaha.118.039100
View
Nowakowska, M., Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., et al. (2019). The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. http://doi.org/10.1186/s12916-019-1373-y
View